Page last updated: 2024-10-21

5-dimethylamiloride and Barrett Esophagus

5-dimethylamiloride has been researched along with Barrett Esophagus in 1 studies

5-dimethylamiloride: has anti-HIV-1 activity

Barrett Esophagus: A condition with damage to the lining of the lower ESOPHAGUS resulting from chronic acid reflux (ESOPHAGITIS, REFLUX). Through the process of metaplasia, the squamous cells are replaced by a columnar epithelium with cells resembling those of the INTESTINE or the salmon-pink mucosa of the STOMACH. Barrett's columnar epithelium is a marker for severe reflux and precursor to ADENOCARCINOMA of the esophagus.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fitzgerald, RC1
Omary, MB1
Triadafilopoulos, G1

Other Studies

1 other study available for 5-dimethylamiloride and Barrett Esophagus

ArticleYear
Altered sodium-hydrogen exchange activity is a mechanism for acid-induced hyperproliferation in Barrett's esophagus.
    The American journal of physiology, 1998, Volume: 275, Issue:1

    Topics: Amiloride; Barrett Esophagus; Cell Division; Cell Line; Esophagus; Humans; Hydrogen-Ion Concentratio

1998